Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

被引:55
作者
Vargas-Franco, Jorge W. [1 ,2 ]
Castaneda, Beatriz [3 ]
Redini, Francoise [1 ]
Gomez, David F. [2 ]
Heymann, Dominique [4 ,5 ]
Lezot, Frederic [1 ]
机构
[1] Univ Nantes, Fac Med, INSERM, UMR 1238,Equipe 1, Nantes, France
[2] Univ Antioquia, Fac Odontol, Dept Basic Studies, Medellin, Colombia
[3] Ctr Rech Cordeliers, INSERM, Equipe 5, UMR 1138, Paris, France
[4] Univ Sheffield, Sch Med, Dept Oncol & Human Metab, INSERM,LEA Sarcoma Res Unit, Sheffield, S Yorkshire, England
[5] INSERM, Inst Cancerol Ouest, UMR 1232, Site Rene Gauducheau,Blvd Prof Jacques Monod, St Herblain, France
关键词
bisphosphonates; side effects; skeleton; MEDICATION-RELATED OSTEONECROSIS; NITROGEN-CONTAINING BISPHOSPHONATES; BONE MORPHOGENETIC PROTEIN; ZOLEDRONIC ACID; OSTEOGENESIS-IMPERFECTA; TOOTH ERUPTION; IN-VITRO; JAW; ALENDRONATE; MANAGEMENT;
D O I
10.1002/jcp.26465
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bisphosphonates are considered the most effective drugs for controlling adult and pediatric osteolytic diseases. Although they have been used successfully for many years, several side effects, such as osteonecrosis of the jaw, delayed dental eruption, atypical femoral fracture, and alterations to the bone growth system, have been described. After an overview of nitrogenous bisphosphonate, the purpose of this article is to describe their mechanisms of action and current applications, review the preclinical and clinical evidence of their side effects in the skeleton (what we know), and describe current recommendations for preventing and managing these effects (what we can do). Finally, promising future directions on how to limit the occurrence of these side effects will be presented.
引用
收藏
页码:5696 / 5715
页数:20
相关论文
共 106 条
[1]   Pathophysiology of Osteonecrosis of the Jaws [J].
Aghaloo, Tara ;
Hazboun, Renna ;
Tetradis, Sotirios .
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) :489-+
[2]   RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease [J].
Aghaloo, Tara L. ;
Cheong, Simon ;
Bezouglaia, Olga ;
Kostenuik, Paul ;
Atti, Elisa ;
Dry, Sarah M. ;
Pirih, Flavia Q. ;
Tetradis, Sotirios .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (04) :843-854
[3]   Zebra lines of pamidronate therapy in children [J].
Al Muderis, M. ;
Azzopardi, T. ;
Cundy, P. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2007, 89A (07) :1511-1516
[4]   A Review of Osteoporosis in the Older Adult [J].
Alejandro, Paloma ;
Constantinescu, Florina .
CLINICS IN GERIATRIC MEDICINE, 2017, 33 (01) :27-+
[5]   Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates [J].
Allen, Matthew R. .
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) :497-+
[6]  
Allen MatthewR., 2014, Basic and Applied Bone Biology
[7]   Atypical Femoral Fractures, Bisphosphonates, and Mechanical Stress [J].
Aspenberg, Per ;
Schilcher, Jorg .
CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (02) :189-193
[8]   The Use of Bisphosphonates in Pediatrics [J].
Baroncelli, Giampiero I. ;
Bertelloni, Silvano .
HORMONE RESEARCH IN PAEDIATRICS, 2014, 82 (05) :290-302
[9]   Impact of Oncopediatric Dosing Regimen of Zoledronic Acid on Bone Growth: Preclinical Studies and Case Report of an Osteosarcoma Pediatric Patient [J].
Battaglia, Severine ;
Dumoucel, Sophie ;
Chesneau, Julie ;
Heymann, Marie-Francoise ;
Picarda, Gaelle ;
Gouin, Francois ;
Corradini, Nadege ;
Heymann, Dominique ;
Redini, Francoise .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (10) :2439-2451
[10]   Strategies for delivering bone morphogenetic protein for bone healing [J].
Begam, Howa ;
Nandi, Samit Kumar ;
Kundu, Biswanath ;
Chanda, Abhijit .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 70 :856-869